The IPKat

SEPTEMBER 4, 2023

The judge also found Yeda to be entirely consistent with the (latest) CJEU case law on the topic, specifically Santen ( C-673/18 ) (para. May 2021) New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel) (March 2022)

Art 117

Art Marketing Marketing Patent 117

SpicyIP

JULY 26, 2021

Topical Highlight. In this post , Praharsh discussed the recent Delhi High Court order vacating an ex-parte interim injunction, allowing the SMS Pharmaceuticals to export Merck’s patented anti-diabetic drug ‘Sitagliptin’ for R&D purposes. The Delhi High Court in Merck Sharp and Dohme Corp. July 20, 2021].

Copyright 97

Copyright Patent Television Intellectual Property 97

SpicyIP

JANUARY 2, 2022

This year, we have divided these developments into three categories: a) Top 10 IP Judgments/Orders (Topicality/Impact). Top 10 Judgments/Orders [Topicality/Impact]. Merck Sharp and Dohme v. b) Top 10 IP Judgments/Orders (Jurisprudence/Legal Lucidity) and. c) Top 10 Other IP Developments. H Lundbeck A/S v. In H Lundbeck A/S v.

IP 143

IP Intellectual Property Copyright Trademark 143

SpicyIP

JULY 21, 2021

The bone of contention in the present case is the patented drug, Sitagliptin, registered under the name of Merck Sharp and Dohme Corporation (Plaintiff) and bearing Indian Patent no. see here for our previous coverage on the Bolar exception and fans of an exhaustive reading on the topic can access the paper by Prof. Background .

Patent 98

Patent Advertising Advertising Law 98

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Ontruzant ® (Samsung Bioepis/ Merck). Renflexis ® (Samsung Bioepis/Merck). Herceptin ® (Roche / Genentech). trastuzumab-qyyp. March 11, 2019. first submission June 22, 2017; resubmitted Sept. February 15, 2020. 22% off WAC of Herceptin ®. Herceptin ® (Roche / Genentech). trastuzumab-dttb. January 18, 2019. April 15, 2020.

Litigation 52

Litigation Settlement Patent Marketing 52